Daily Study

A mostly flat session: SPY +0.27%, QQQ +1.27%

Three screens filtered 1,911 US stocks down to 12 names on this page: the top and the bottom of each ordering. 4 of 12 closed lower and 8 higher; small caps (IWM) moved +0.95%.

SPY+0.27%
S&P 500 ETF735.23
QQQ+1.27%
Nasdaq 100 ETF656.31
IWM+0.95%
Russell 2000 ETF273.64
DIA−0.46%
Dow 30 ETF512.21
names screened
1,911
studied in depth
144
on this page
12
screens
3

A record of what moved, not a recommendation.Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRLMethodologyDisclaimer

Each screen starts from a broad filter of US stocks; the candidates are then ordered by a combined fundamentals-and-trend read. The page shows the names at the top and at the bottom of that order, so you see both ends of the same filter, not a pick list. Open any case study for the session, the three-month trend and the latest SEC financials. IEX volume is only the share traded on IEX, so it is compared with its own 20-day average.

Learn more: Top and Bottom of the Screen: An Ordering, Not a Verdict · Where the Numbers Come From: IEX Prices and SEC Filings

514matched the screen
60studied in depth
4on this page

Top of the screen

VFF

Village Farms International Inc

2.88+3.8%
Consumer DefensiveFarm Products
3 months+18.7%
52-week range52w low34%high
RSI (14)59
Session
at VWAP 2.881.31× avg vol
Moving averages
above 50dabove 200d
View VFF chart on TradingView Affiliate
Case study: why VFF is on this page

Landed at the top of today's combined fundamentals-and-trend screen for this group: reported a net profit in its latest fiscal year; annual revenue grew 10% year over year; price sits above its 200-day average; moved +18.7% over the last three months.

Close 2.88: +3.8% vs previous closeSession (open→close): +4.3%

Session: day range 2.77–2.93, VWAP 2.88 (at VWAP), IEX volume 1.31× its 20-day average. Trend: +18.7% over three months, 34% of the way up its 52-week range, RSI(14) 59, above its 50-day and above its 200-day average.

Intraday chart of VFF on 2026-11-06
Session (intraday)
Three-month daily chart of VFF
Three months (daily)
Revenue (latest FY)
$215.9M
Net income (latest FY)
$32.4M
Cash
$72.9M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Village Farms International Inc filings on SEC EDGAR

CRCT

Cricut Inc

8.77−5.0%
TechnologyComputer Hardware
3 months+46.7%
52-week range52w low85%high
RSI (14)75
Session
at VWAP 8.751.47× avg vol
Moving averages
above 50dabove 200d
View CRCT chart on TradingView Affiliate
Case study: why CRCT is on this page

Landed at the top of today's combined fundamentals-and-trend screen for this group: reported a net profit in its latest fiscal year; annual revenue shrank 1% year over year; price sits above its 200-day average; moved +46.7% over the last three months.

Close 8.77: −5.0% vs previous closeSession (open→close): −2.9%

Session: day range 8.55–9.04, VWAP 8.75 (at VWAP), IEX volume 1.47× its 20-day average. Trend: +46.7% over three months, 85% of the way up its 52-week range, RSI(14) 75, above its 50-day and above its 200-day average.

Intraday chart of CRCT on 2026-11-06
Session (intraday)
Three-month daily chart of CRCT
Three months (daily)
Revenue (latest FY)
$708.8M
Net income (latest FY)
$76.7M
Cash
$174.6M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Cricut Inc filings on SEC EDGAR

Bottom of the screen

PROK

ProKidney Corp

1.15+8.0%
HealthcareBiotechnology
3 months−28.6%
52-week range52w low13%high
RSI (14)37
Session
above VWAP 1.120.70× avg vol
Moving averages
below 50dbelow 200d
View PROK chart on TradingView Affiliate
Case study: why PROK is on this page

Landed at the bottom of today's combined fundamentals-and-trend screen for this group: reported a net loss in its latest fiscal year; annual revenue grew 1075% year over year; price sits below its 200-day average; moved -28.6% over the last three months.

Close 1.15: +8.0% vs previous closeSession (open→close): +10.0%

Session: day range 1.04–1.16, VWAP 1.12 (above VWAP), IEX volume 0.70× its 20-day average. Trend: −28.6% over three months, 13% of the way up its 52-week range, RSI(14) 37, below its 50-day and below its 200-day average.

Intraday chart of PROK on 2026-11-06
Session (intraday)
Three-month daily chart of PROK
Three months (daily)
Revenue (latest FY)
$893.0K
Net income (latest FY)
−$69.0M
Cash
$74.9M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: ProKidney Corp filings on SEC EDGAR

ARTV

Artiva Biotherapeutics Inc

4.15+0.4%
HealthcareBiotechnology
3 months−64.7%
52-week range52w low10%high
RSI (14)22
Session
below VWAP 4.190.86× avg vol
Moving averages
below 50dbelow 200d
View ARTV chart on TradingView Affiliate
Case study: why ARTV is on this page

Landed at the bottom of today's combined fundamentals-and-trend screen for this group: reported a net loss in its latest fiscal year; annual revenue shrank 100% year over year; price sits below its 200-day average; trading near the bottom of its 52-week range; moved -64.7% over the last three months.

Close 4.15: +0.4% vs previous closeSession (open→close): −1.0%

Session: day range 4.14–4.23, VWAP 4.19 (below VWAP), IEX volume 0.86× its 20-day average. Trend: −64.7% over three months, 10% of the way up its 52-week range, RSI(14) 22, below its 50-day and below its 200-day average.

Intraday chart of ARTV on 2026-11-06
Session (intraday)
Three-month daily chart of ARTV
Three months (daily)
Revenue (latest FY)
$0
Net income (latest FY)
−$83.9M
Cash
$301.5M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Artiva Biotherapeutics Inc filings on SEC EDGAR

1,373matched the screen
60studied in depth
4on this page

Top of the screen

FULT

Fulton Financial Corp

23.77−0.1%
FinancialBanks - Regional
3 months−2.1%
52-week range52w low82%high
RSI (14)56
Session
at VWAP 23.780.82× avg vol
Moving averages
above 50dabove 200d
View FULT chart on TradingView Affiliate
Case study: why FULT is on this page

Landed at the top of today's combined fundamentals-and-trend screen for this group: reported a net profit in its latest fiscal year; annual revenue shrank 7% year over year; price sits above its 200-day average.

Close 23.77: −0.1% vs previous closeSession (open→close): +1.0%

Session: day range 23.52–23.96, VWAP 23.78 (at VWAP), IEX volume 0.82× its 20-day average. Trend: −2.1% over three months, 82% of the way up its 52-week range, RSI(14) 56, above its 50-day and above its 200-day average.

Intraday chart of FULT on 2026-11-06
Session (intraday)
Three-month daily chart of FULT
Three months (daily)
Revenue (latest FY)
$276.8M
Net income (latest FY)
$391.6M
Cash
$1.11B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Fulton Financial Corp filings on SEC EDGAR

GEN

Gen Digital Inc

29.77−2.7%
TechnologySoftware - Infrastructure
3 months+2.7%
52-week range52w low86%high
RSI (14)67
Session
below VWAP 29.990.66× avg vol
Moving averages
above 50dabove 200d
View GEN chart on TradingView Affiliate
Case study: why GEN is on this page

Landed at the top of today's combined fundamentals-and-trend screen for this group: reported a net profit in its latest fiscal year; annual revenue grew 27% year over year; price sits above its 200-day average.

Close 29.77: −2.7% vs previous closeSession (open→close): −1.0%

Session: day range 29.67–30.47, VWAP 29.99 (below VWAP), IEX volume 0.66× its 20-day average. Trend: +2.7% over three months, 86% of the way up its 52-week range, RSI(14) 67, above its 50-day and above its 200-day average.

Intraday chart of GEN on 2026-11-06
Session (intraday)
Three-month daily chart of GEN
Three months (daily)
Revenue (latest FY)
$5.00B
Net income (latest FY)
$973.0M
Cash
$589.0M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Gen Digital Inc filings on SEC EDGAR

Bottom of the screen

KURA

Kura Oncology Inc

7.25+7.3%
HealthcareBiotechnology
3 months−26.9%
52-week range52w low7%high
RSI (14)29
Session
above VWAP 7.081.02× avg vol
Moving averages
below 50dbelow 200d
View KURA chart on TradingView Affiliate
Case study: why KURA is on this page

Landed at the bottom of today's combined fundamentals-and-trend screen for this group: reported a net loss in its latest fiscal year; annual revenue grew 25% year over year; price sits below its 200-day average; trading near the bottom of its 52-week range; moved -26.9% over the last three months.

Close 7.25: +7.3% vs previous closeSession (open→close): +4.9%

Session: day range 6.77–7.39, VWAP 7.08 (above VWAP), IEX volume 1.02× its 20-day average. Trend: −26.9% over three months, 7% of the way up its 52-week range, RSI(14) 29, below its 50-day and below its 200-day average.

Intraday chart of KURA on 2026-11-06
Session (intraday)
Three-month daily chart of KURA
Three months (daily)
Revenue (latest FY)
$67.5M
Net income (latest FY)
−$278.7M
Cash
$70.2M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Kura Oncology Inc filings on SEC EDGAR

GPCR

Structure Therapeutics Inc ADR

20.38+7.0%
HealthcareBiotechnology
3 months−60.9%
52-week range52w low2%high
RSI (14)30
Session
above VWAP 19.981.87× avg vol
Moving averages
below 50dbelow 200d
View GPCR chart on TradingView Affiliate
Case study: why GPCR is on this page

Landed at the bottom of today's combined fundamentals-and-trend screen for this group: reported a net loss in its latest fiscal year; price sits below its 200-day average; trading near the bottom of its 52-week range; moved -60.9% over the last three months.

Close 20.38: +7.0% vs previous closeSession (open→close): +4.4%

Session: day range 18.71–21.30, VWAP 19.98 (above VWAP), IEX volume 1.87× its 20-day average. Trend: −60.9% over three months, 2% of the way up its 52-week range, RSI(14) 30, below its 50-day and below its 200-day average.

Intraday chart of GPCR on 2026-11-06
Session (intraday)
Three-month daily chart of GPCR
Three months (daily)
Revenue (latest FY)
n/a
Net income (latest FY)
−$141.2M
Cash
$272.6M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Structure Therapeutics Inc ADR filings on SEC EDGAR

24matched the screen
24studied in depth
4on this page

Top of the screen

IDXX

Idexx Laboratories Inc

676.26+0.8%
HealthcareDiagnostics & Research
3 months+15.2%
52-week range52w low65%high
RSI (14)71
Session
at VWAP 673.910.75× avg vol
Moving averages
above 50dabove 200d
View IDXX chart on TradingView Affiliate
Case study: why IDXX is on this page

Landed at the top of today's combined fundamentals-and-trend screen for this group: reported a net profit in its latest fiscal year; annual revenue grew 10% year over year; price sits above its 200-day average; moved +15.2% over the last three months.

Close 676.26: +0.8% vs previous closeSession (open→close): +3.4%

Session: day range 653.75–679.32, VWAP 673.91 (at VWAP), IEX volume 0.75× its 20-day average. Trend: +15.2% over three months, 65% of the way up its 52-week range, RSI(14) 71, above its 50-day and above its 200-day average.

Intraday chart of IDXX on 2026-11-06
Session (intraday)
Three-month daily chart of IDXX
Three months (daily)
Revenue (latest FY)
$4.30B
Net income (latest FY)
$1.06B
Cash
$197.5M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Idexx Laboratories Inc filings on SEC EDGAR

AAPL

Apple Inc

342.41−0.6%
TechnologyConsumer Electronics
3 months+12.3%
52-week range52w low88%high
RSI (14)51
Session
at VWAP 342.980.95× avg vol
Moving averages
above 50dabove 200d
View AAPL chart on TradingView Affiliate
Case study: why AAPL is on this page

Landed at the top of today's combined fundamentals-and-trend screen for this group: reported a net profit in its latest fiscal year; annual revenue grew 15% year over year; price sits above its 200-day average.

Close 342.41: −0.6% vs previous closeSession (open→close): +1.1%

Session: day range 338.59–345.76, VWAP 342.98 (at VWAP), IEX volume 0.95× its 20-day average. Trend: +12.3% over three months, 88% of the way up its 52-week range, RSI(14) 51, above its 50-day and above its 200-day average.

Intraday chart of AAPL on 2026-11-06
Session (intraday)
Three-month daily chart of AAPL
Three months (daily)
Revenue (latest FY)
$478.83B
Net income (latest FY)
$132.18B
Cash
$36.30B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Apple Inc filings on SEC EDGAR

Bottom of the screen

NVDA

NVIDIA Corp

186.70+2.8%
TechnologySemiconductors
3 months−14.1%
52-week range52w low28%high
RSI (14)31
Session
below VWAP 189.221.63× avg vol
Moving averages
below 50dbelow 200d
View NVDA chart on TradingView Affiliate
Case study: why NVDA is on this page

Landed at the bottom of today's combined fundamentals-and-trend screen for this group: reported a net profit in its latest fiscal year; annual revenue grew 65% year over year; price sits below its 200-day average.

Close 186.70: +2.8% vs previous closeSession (open→close): −2.4%

Session: day range 185.22–194.89, VWAP 189.22 (below VWAP), IEX volume 1.63× its 20-day average. Trend: −14.1% over three months, 28% of the way up its 52-week range, RSI(14) 31, below its 50-day and below its 200-day average.

Intraday chart of NVDA on 2026-11-06
Session (intraday)
Three-month daily chart of NVDA
Three months (daily)
Revenue (latest FY)
$215.94B
Net income (latest FY)
$120.07B
Cash
$22.44B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: NVIDIA Corp filings on SEC EDGAR

UI

Ubiquiti Inc

593.74+15.3%
TechnologyCommunication Equipment
3 months+3.5%
52-week range52w low16%high
RSI (14)52
Session
at VWAP 591.871.95× avg vol
Moving averages
above 50dbelow 200d
View UI chart on TradingView Affiliate
Case study: why UI is on this page

Landed at the bottom of today's combined fundamentals-and-trend screen for this group: reported a net profit in its latest fiscal year; annual revenue grew 27% year over year; price sits below its 200-day average.

Close 593.74: +15.3% vs previous closeSession (open→close): +2.4%

Session: day range 575.00–605.75, VWAP 591.87 (at VWAP), IEX volume 1.95× its 20-day average. Trend: +3.5% over three months, 16% of the way up its 52-week range, RSI(14) 52, above its 50-day and below its 200-day average.

Intraday chart of UI on 2026-11-06
Session (intraday)
Three-month daily chart of UI
Three months (daily)
Revenue (latest FY)
$3.27B
Net income (latest FY)
$960.3M
Cash
$549.4M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Ubiquiti Inc filings on SEC EDGAR

The charts use the candlestick, VWAP and moving-average reading taught in our free courses. To pull up any of these tickers yourself, TradingView’s free plan covers it. Affiliate link: we may earn a commission if you subscribe, at no extra cost to you.

Reminder: nothing on this page is investment advice. These names appear because of where they landed in the screen, not because of any view on where the price goes next. Past performance does not indicate future results. See the Disclaimer.